Principles of Modern Prevention of Nephropathy in Children

Akhmatov  Ablokul; Muhammadjon Ablokulovich Akhmatov

Akhmatov Ablokul Associate Professor, Candidate of Medical Sciences, Department of Pediatrics-2, Samarkand State Medical University, Samarkand, Uzbekistan
Muhammadjon Ablokulovich Akhmatov Student, 2nd Medical Faculty, Samarkand State Medical University, Samarkand, Uzbekistan.

Keywords: children, kidneys, dysmetabolic nephropathy, chronic kidney disease, chronic kidney failure, preventive prevention

Abstract

Based on our own research and recent literature data, we have studied risk factors influencing the formation and progression of nephropathies (hereditary, teratogenic, external environmental). With timely detection and adherence to simple preventive measures (diet, fluid regimen, microclimate, elimination of infectious, toxic, allergic effects, and dysmetabolism correction), they do not lead to complications (interstitial nephritis (IN), urolithiasis (UTI), secondary dysmetabolism (SD), secondary pyelonephritis). External environmental factors contributing to the manifestation of pathology in children with metabolic disorders include seasonal climatic fluctuations - adaptation to low and high temperatures, dietary errors, emotional and physical overloads, membranopathies, and intercurrent diseases. It has been established that the presence of latent diathesis in a child from a family with a predisposition to certain diseases (ancestry, hereditary burden index) is determined using biochemical, immunological, and functional studies. A scheme for the preventive prevention and metaphylaxis of nephropathies in uric acid diathesis has been developed.

References

[1] N. I. Averyanova and L. G. Baluyeva, "Treatment and prevention of relapses of pyelonephritis with crystalluria in children," Russian Bulletin of Perinatology and Pediatrics, vol. 61, no. 6, pp. 104–108, 2016.
[2] A. Akhmatov, Yu. A. Akhmatova, M. K. Azizov, and G. D. Ishkabulova, "Modern aspects of preventive prevention and metaphylaxis of nephropathies in uric acid diathesis," in Proc. VIII Congress of Pediatricians of Uzbekistan, Tashkent, Uzbekistan, Oct. 2019, pp. 25–26.
[3] A. Akhmatov, Yu. A. Akhmatova, D. U. Melikova, Sh. R. Najimov, et al., "Age, sex, and nosological structure of patients hospitalized in the specialized department of the multidisciplinary children's center," in Proc. Int. Sci. Pract. Conf. "Actual Issues of Nephrology", Tashkent, Uzbekistan, Mar. 2019, pp. 18–19.
[4] A. A. Vyalkova, V. A. Gritsenko, L. S. Zykova, and L. M. Gordienko, "Urinary System Infection in Children in the 21st Century," Orenburg Medical Herald, no. 2(14), pp. 49–56, 2016.
[5] A. A. Vyalkova, I. V. Zorin, S. A. Chesnokova, and S. V. Plotnikova, "Early diagnosis of chronic kidney disease in children," Nephrology, vol. 23, no. 8, pp. 135–136, 2019.
[6] M. A. Daminova, "Chronic kidney disease in children: etiology, classification and factors of progression," Bulletin of Modern Clinical Medicine, vol. 9, pp. 36–41, 2016.
[7] S. V. Rychkova, "Dysmetabolic Nephropathies in Pediatric Practice," Treating Doctor, no. 8, pp. 11–15, 2010.
[8] G. A. Serova and S. S. Paunova, "Urinary System Infection in Children," Nephrology and Dialysis, vol. 9, no. 1, pp. 86–91, 2017.
[9] A. A. Tolganbayeva and G. N. Chingayeva, "Chronic kidney disease in children - a modern view (literature review)," KazNMU Bulletin, no. 1, pp. 185–190, 2019.
[10] G. A. Block, D. A. Bushinsky, S. Cheng, et al., "Effect of Ethelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis with Secondary Hyperparathyroidism. A Randomized Clinical Trial," JAMA, vol. 317, no. 2, pp. 156–164, 2017.
[11] J. L. Carpenter, S. C. Fallon, and S. J. Swartz, et al., "Outcomes after peritoneal dialysis catheter placement," Journal of Pediatric Surgery, vol. 51, no. 5, pp. 730–733, 2016.
[12] N. C. Chesnaye, F. Schaefer, M. Bonthuis, R. Holman, et al., "Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage kidney disease across Europe: an ESPN-ERA/EDTA registry analysis," The Lancet, vol. 389, no. 10084, pp. 2128–2137, 2017.
[13] K. Musiał, M. Sałamacha, S. Gralec, A. Pers, Ł. Jacheć, and D. Zwolińska, "Summary of KDIGO 2012 / Chronic kidney disease in children under 2 years old - a single center data analysis," MEDPRESS, vol. 44, no. 262, pp. 188–191, 2018.
[14] J. F. Rizaev, Z. F. Ashirov, S. U. Toshev, et al., "Medical and organizational measures to improve the provision of medical care in the dermatovenerological profile," International Journal of Current Research and Review, vol. 12, no. 24, pp. 120–122, 2020.
[15] S. Ziyadullaev, J. R. Alimdjanovich, I. A. Rubenovna, et al., "Effects of budesonide on the quality of life in patients with bronchial asthma," European Journal of Molecular and Clinical Medicine, vol. 7, no. 2, pp. 1760–1766, 2020.

Electronic resources:
[16] G. P. Arutyunov and D. O. Dragunov, "Chronic kidney disease," Moscow, 2019. [Online]. Available: https://www.fresenius-kabi.com/ru/documents/arutyunov_dragunov.pdf
[17] A. Yu. Nikolaev, N. L. Livshits, and Yu. S. Milovanov, "Diagnosis and principles of treatment of chronic renal failure," RMJ, 2019. [Online]. Available: https://www.rmj.ru/articles/urologiya/
[18] World Health Organization, "Report on the situation in the field of non-communicable diseases in the world 2014," Geneva, 2019. [Online]. Available: https://www.who.int/nmh/publications/ncd-status-report-2014/ru/